Long-term outcome after combined radiochemotherapy for anal cancer - Retrospective analysis of efficacy, prognostic factors, and toxicity

Onkologie

Volumn 31, Issue 5, 2008, Pages 251-257

  Mai, Sabine K ^a   Welzel, Grit ^a   Hermann, Brigitte ^a   Bohrer, Markus ^a   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anal cancer; Radiochemotherapy: efficacy, prognostic factors, toxicity

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; COLOSTOMY; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 44349168840     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121362     Document Type: Article

References (41)

1. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK: Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
2. Chiao EY, Krown SE, Stier EA, Schrag D: A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005;40:451-5.
3. Nigro ND, Vaitkevicius VK, Considine B Jr: Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-6.
4. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
5. UKCCR: Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996;348:1049-54.
6. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39.
7. Peiffert D, Giovannini M, Ducreux M, Michel P, Francois E, Lemanski C, Mirabel X, Cvitkovic F, Luporsi E, Conroy T, Gerard JP: High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Ann Oncol 2001;12:397-404.
8. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN: Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:1115-25.
9. Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG: Epidermoid cancer of the anorectum. Cancer 1984;53:1285-93.
10. Mai SK, Grieger J, Lachmann R, Bohrer M, Tiefenbacher U, Wenz F: Radiochemotherapy for anal carcinoma - effectivity and late toxicity. Onkologie 2002;25:55-9.
11. Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, van der Steen-Banasik E, Triviere N, Stuben G, Puyraveau M, Mercier M: Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 2003;39:45-51.
12. Trog D, Wendt TG: Organ-preserving radiochemotherapy of the anal carcinoma. Onkologie 1998;21:130-5.
13. Peiffert D, Bey P, Pernot M, Hoffstetter S, Marchal C, Beckendorf V, Guillemin F: Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys 1997;39:57-66.
14. Bedenne L, Janoray I, Arveux P, Horiot JC, Janoray P, Ledorze C, Altwegg T, Faivre J: Le cancer épidermoïde du canal anal dans le département de la Côte d'Or. Gastroenterol Clin Biol 1989;15:130-6.
15. Papillon J: Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1990;19:1217-8.
16. Salmon RJ, Zafrani B, Labib A, Asselain B, Girodet J, Durand JC, Fenton J, Mathieu G, Bataini P, Rousseau J, et al.: [Cancer of the anal canal. Results of the treatment of a series of 195 cases]. Gastroenterol Clin Biol 1985;9:911-7.
17. Schlienger M, Krzisch C, Pene F, Marin JL, Gindrey-Vie B, Mauban S, Barthelemy N, Habrand JL, Socie G, Parc R, et al.: Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 1989;17:1141-51.
18. Sischy B, Doggett RL, Krall JM, Taylor DG, Sause WT, Lipsett JA, Seydel HG: Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 1989;81:850-6.
19. Touboul E, Schlienger M, Hadjrabia S, Laugier A: [Cancer of the anal canal; role of radiotherapy and combinations of chemotherapy and radiotherapy]. Rev Med Interne 1993;14:340-9.
20. Wagner JP, Mahe MA, Romestaing P, Rocher FP, Berger C, Trillet-Lenoir V, Gerard JP: Radiation therapy in the conservative treatment of carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1994;29:17-23.
21. Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A: Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005;61:1136-42.
22. Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, Romestaing P, Favrel V, Mornex F, Bobin JY: Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001;92:77-84.
23. Belkacemi Y, Berger C, Poortmans P, Piel G, Zouhair A, Meric JB, Nguyen TD, Krengli M, Behrensmeier F, Allal A, De Looze D, Bernier J, Scandolaro L, Mirimanoff RO: Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2003;56:1274-83.
24. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH: Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007;68:794-800.
25. Akbari RP, Paty PB, Guillem JG, Weiser MR, Temple LK, Minsky BD, Saltz L, Wong WD: Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004;47:1136-44.
26. Nilsson PJ, Svensson C, Goldman S, Ljungqvist O, Glimelius B: Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 2005;61:92-102.
27. Goldman S, Glimelius B, Glas U, Lundell G, Pahlman L, Stahle E: Management of anal epidermoid carcinoma-an evaluation of treatment results in two population-based series. Int J Colorectal Dis 1989;4:234-43.
28. Mai SK, Welzel G, Haegele V, Wenz F: The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer. Radiat Oncol 2007;2:30.
29. Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH: Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 2005;48:1742-51.
30. Peiffert D, Seitz JF, Rougier P, Francois E, Cvitkovic F, Mirabel X, Nasca S, Ducreux M, Hannoun-Levi JM, Lusinchi A, Debrigode E, Conroy T, Pignon JP, Gerard JP: Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study. Ann Oncol 1997;8:575-81.
31. Grabenbauer GG, Matzel KE, Schneider IH, Meyer M, Wittekind C, Matsche B, Hohenberger W, Sauer R: Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases? Dis Colon Rectum 1998;41:441-50.
32. Bieri S, Allal AS, Kurtz JM: Sphincter-conserving treatment of carcinomas of the anal margin. Acta Oncol 2001;40:29-33.
33. Papillon J, Chassard JL: Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients. Dis Colon Rectum 1992;35:422-9.
34. Cutuli B, Fenton J, Labib A, Bataini JP, Mathieu G: Anal margin carcinoma: 21 cases treated at the Institut Curie by exclusive conservative radiotherapy. Radiother Oncol 1988;11:1-6.
35. Varnai AD, Bollmann M, Griefingholt H, Speich N, Schmitt C, Bollmann R, Decker D: HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 2006;21:135-42.
36. Daling JR, Sherman KJ: Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 1992;(119):223-41.
37. Frisch M: On the etiology of anal squamous carcinoma. Dan Med Bull 2002;49:194-209.
38. Frisch M, Fenger C, van den Brule AJ, Sorensen P, Meijer CJ, Walboomers JM, Adami HO, Melbye M, Glimelius B: Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59:753-7.
39. Tanum G, Holm R: Anal carcinoma: a clinical approach to p53 and RB gene proteins. Oncology 1996;53:369-73.
40. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM: Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999;80:1588-94.
41. Vordermark D, Sailer M, Flentje M, Thiede A, Kolbl O: Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 1999;52:239-43.